New Concept Energy, Inc. (NYSE:GBR) tinted gains of +3.59% (+0.12 points) to US$3.46. The volume of 0.53 Million shares climbed down over an trading activity of 1.18 Million shares. EPS ratio determined by looking at last 12 month figures is -1.41. Over the same time span, the stock marked US$12.75 as its best level and the lowest price reached was US$1.16. The corporation has a market cap of US$7.16 Million.
New Concept Energy, Inc. (NYSE:GBR)’s earnings per share has been growing at a 0 percent rate over the past 5 year when average revenue increase was noted as -27.5 percent. The return on equity ratio or ROE stands at 0 percent while most common profitability ratio return on investment (ROI) was -363.3 percent. The company’s institutional ownership is monitored at 4.1 percent. The company’s net profit margin has achieved the current level of 0 percent and possesses -30.8 percent gross margin.
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) is worth US$344.64 Million and has recently risen 3.57% to US$2.9. The latest exchange of 2.25 Million shares is above its average trading activity of 1.84 Million shares. The day began at US$2.82 but the price moved to US$2.8 at one point during the trading and finally capitulating to a session high of US$2.91. The stock tapped a 52-week high of US$4.24 while the mean 12-month price target for the shares is US$5.67.
Currently, the stock carries a price to earnings ratio of 0, a price to book ratio of 0, and a price to sales ratio of 56.5. For the past 5 years, the company’s revenue has grown -17%, while the company’s earnings per share has grown 25.3%. With an institutional ownership near 51.8%, it carries an earnings per share ratio of -0.57.
Inside Look At Analysts Reviews
Latest analyst recommendations could offer little help to investors. The stock is a Buy among 0 brokerage firms polled by Factset Research. At present, 0 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data. 0 analysts call it Underweight, while 3 think it is Overweight. Recently, investment analysts covering the stock have updated the mean rating to 2.